NeuroDiversity Consulting LLC
  • Home
    • Our Mission
  • Events
    • Conferences
  • Autism Attitude
  • Contact Us

The Endocannabinoid System

7/30/2014

0 Comments

 
This post is part of the series Examining the Use of Medical Marijuana for ASD Treatment.

Scientists have identified an endocannabinoid system within the brain. It is so called because the naturally occurring neurotransmitters (chemical messengers that control the function of nerve cells in the brain) that control the endocannabinoid system resemble the active compounds, cannabinoids, found in plants of the genus Cannabis. The two known endocannabinoid neurotransmitters are anandamide and 2-arachidonyglycerol, thankfully referred to as 2AG for those not comfortable with the language of organic chemistry. They are classified as unconventional or atypical neurotransmitters because they do not behave as more familiar neurotransmitters do. There are likely more endocannabinoids that have not yet been identified.

The endocannabinoids interact with specific receptors (gates in the membranes of nerve cells made of proteins that open and close under specific circumstances) distributed throughout the brain. These are the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors, so named because they were found to interact with the psychoactive ingredients in marijuana. The CB1 receptor is found in many areas of the brain. These areas include:

·         cerebellum: responsible for producing smooth, well-coordinated, multi-jointed movements (e.g. walking, running, writing), learning skilled movements (e.g. playing an instrument)

·         hippocampus: memory

·         basal ganglia: organization and guidance of complex motor functions, regulate cognitive functions (memory and learning), regulate emotional and motivated behavior

·         cortex: sensory and motor function, sensory processing, learning, planning and decision making, language processing, attention, cognition

·         brainstem: regulation of upper and lower body movements (balance, posture, gaze), sensory and motor functions of head and neck, regulates the level consciousness

·         thalamus: amplifies, computes, and communicates sensory and motor information to the cortex; mediates attention, mood change, behavioral arousal, and transitions in sleep and wakefulness

·         hypothalamus: regulates internal states (blood pressure, body temperature, emergency responses, etc.)

The CB2 receptor is more limited in its distribution but can also be found in the brainstem. The wide distribution of the CB1 receptor means that it has significant influence on just about every function of the brain. Just as there are likely other endocannabinoids yet to be discovered there are likely other unidentified receptors that are part of the endocannabinoid system.

Anandamide and 2AG serve as traffic regulators at the synapses where they are found. They are released by neurons when electrical signals come into the cell. The endocannabinoids slow down the signals traveling across a synapse by telling the previous neuron in the sequence of neurons to stop sending signals across the synapse. The effects of these endocannabinoids can last for seconds, minutes, or hours depending on what type of neuron is being inhibited.

In addition to the endocannabinoids and their receptors the brain also has a mechanism for dispensing with the endocannabinoids once they have done their job. There are a number of enzymes that break down anandamide and 2AG once their function is no longer needed. Researchers have been exploring ways to exploit the various parts of the endocannabinoid system in order to treat and control chronic pain, anxiety, depression, and obesity.


Next in the series, The Cannabinoids.
0 Comments

Examining the Use of Medical Marijuana for ASD Treatment

7/30/2014

0 Comments

 
With the recent passage of medical marijuana legislation in New York state parents of children on the autism spectrum are beginning to explore using medical marijuana to treat their children. There have been reported cases of parents treating their children on the spectrum with Cannabis products. While the practice is controversial and the discourse emotionally charged parents need a clear understanding of the facts about how medical marijuana may impact the children under their care. What follows is a summary of what medical neuroscience and neuropharmacology can tell us about the potential utility of medical marijuana as a treatment for autism spectrum disorders.

The Endocannabinoid System
The Cannabinoids
ASD and the Endocannabinoid System
ASD and the Cannabinoids
NYS Medical Marijuana Law Summary
ASD and Medical Marijuana References




0 Comments

    Categories

    All
    504 Plan
    ABLE 2.0
    ABLE Act 2014
    ACE
    Aspergers
    Autism
    Autism Acceptance
    Autism Advisory Board
    Autism Awareness
    Autism Spectrum Disorder
    Autistic Adults
    Autistic Children
    Behavior Intervention Plan
    BIP
    Church
    Cure
    Diagnosis
    Diet
    Disability
    Discipline
    Diy
    Dsm
    Education
    Education Law
    Encouragement
    Epidemic
    Estate Planning
    Faith
    FBA
    Functional Behavioral Assessment
    Homeschooling
    IDEA
    IEP
    Incidence
    Inclusion
    Laws
    Long Term Care
    Mental Health
    Neurodevelopmental Disorder
    Neurodiversity
    New York
    Nha
    Nurtured Heart Approach
    Parenting
    PDD NOS
    PDD-NOS
    Person/people First Language
    Policy
    Prevalence
    Prevention
    Relativism
    Research
    Resilience
    School
    Science
    Sex
    Social Isolation
    Special Education Law
    Special Needs
    Suspension
    Trauma
    Treatment

    Archives

    May 2020
    September 2019
    August 2019
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    August 2017
    July 2017
    May 2017
    April 2017
    December 2016
    May 2016
    April 2016
    January 2016
    August 2015
    June 2015
    February 2015
    August 2014
    July 2014
    June 2014
    May 2014
    September 2013
    July 2013
    June 2013
    November 2012
    July 2012
    March 2012
    February 2012
    January 2012
    November 2011
    October 2011
    August 2011

      RSS Feed

    NeuroDiversity Consulting LLC
    info@neurodiversityconsulting.org

    (315) 760-4358
     Privacy Policy
    Business Credit
    Business Credit by Nav
    Photo used under Creative Commons from Hayzphotos
    • Home
      • Our Mission
    • Events
      • Conferences
    • Autism Attitude
    • Contact Us